dr. reardon on the immunogenicity of glioblastoma
Published 5 years ago • 497 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
2:09
dr. reardon on efficacy/safety of immunotherapy combination in glioblastoma
-
2:01
dr. reardon on the potential utility of ino-5401 and ino-9012 in glioblastoma
-
1:54
david reardon on caring for patients with glioblastoma
-
2:03
dr. david reardon on immunotherapy and rindopepimut in the glioblastoma treatment paradigm
-
1:20
dr. reardon on the need for a new standard of care in gbm
-
2:01
dr. reardon on nivolumab/ipilimumab in glioblastoma
-
1:34
dr. reardon on pembrolizumab and bevacizumab for glioblastoma
-
2:15
dr. reardon on a phase 1/2 trial examining ino-5401 and ino-9012 in glioblastoma
-
1:05
dr. reardon on updated data from the phase ii react trial
-
1:43
dr. david reardon on treating glioblastoma patients with egfrviii-mutations
-
1:23
dr. reardon on the react trial
-
1:59
dr. reardon on results from the keynote-028 trial
-
1:33
dr. reardon discusses the mechanism of action of rindopepimut for recurrent glioblastoma
-
1:55
asco22: glioblastoma research by david reardon, md | dana-farber cancer institute
-
7:14
glioblastoma: the potential role of immunotherapy
-
0:56
dr. david reardon on targeting brain tumors and monitoring resistances
-
33:11
brain cancer and immunotherapy with dr. david reardon
-
3:18
dr. reardon discusses the react study
-
1:51
the inadequacy of the current standard of care for glioblastoma